House of Lords Business
Show full summary

Lord Mendelsohn to ask Her Majesty's Government when treatments for immunocompromised groups, including monoclonal antibody therapies, will be available as an alternative to COVID-19 vaccines; and which groups will be able to access those treatments.  HL524

Question HL524: tabled on 24 May 2021 and due for answer by 8 June 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask Her Majesty's Government when treatments for immunocompromised groups, including monoclonal antibody therapies, will be available as an alternative to COVID-19 vaccines; and which groups will be able to access those treatments.  HL524
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer